These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30587527)

  • 1. Imaging in multiple myeloma: How? When?
    Zamagni E; Tacchetti P; Cavo M
    Blood; 2019 Feb; 133(7):644-651. PubMed ID: 30587527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern imaging techniques for monitoring patients with multiple myeloma.
    Pop VS; Tomoaia G; Parvu A
    Med Pharm Rep; 2022 Oct; 95(4):377-384. PubMed ID: 36506611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).
    Gleeson TG; Moriarty J; Shortt CP; Gleeson JP; Fitzpatrick P; Byrne B; McHugh J; O'Connell M; O'Gorman P; Eustace SJ
    Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Survey in Multiple Myeloma: Role of Imaging.
    Spinnato P; Filonzi G; Conficoni A; Facchini G; Ponti F; Sambri A; De Paolis M; Cavo M; Salizzoni E; Nanni C
    Curr Med Imaging; 2021; 17(8):956-965. PubMed ID: 33573573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
    Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
    Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
    Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
    Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.
    Rubini G; Niccoli-Asabella A; Ferrari C; Racanelli V; Maggialetti N; Dammacco F
    Crit Rev Oncol Hematol; 2016 May; 101():169-83. PubMed ID: 26997302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.
    Mosebach J; Thierjung H; Schlemmer HP; Delorme S
    Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
    Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
    Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bones in Multiple Myeloma: Imaging and Therapy.
    Zamagni E; Cavo M; Fakhri B; Vij R; Roodman D
    Am Soc Clin Oncol Educ Book; 2018 May; 38():638-646. PubMed ID: 30231385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in myeloma with focus on advanced imaging techniques.
    Barwick T; Bretsztajn L; Wallitt K; Amiras D; Rockall A; Messiou C
    Br J Radiol; 2019 Mar; 92(1095):20180768. PubMed ID: 30604631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of imaging in multiple myeloma.
    Baffour FI; Glazebrook KN; Kumar SK; Broski SM
    Am J Hematol; 2020 Aug; 95(8):966-977. PubMed ID: 32350883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.
    Ormond Filho AG; Carneiro BC; Pastore D; Silva IP; Yamashita SR; Consolo FD; Hungria VTM; Sandes AF; Rizzatti EG; Nico MAC
    Radiographics; 2019; 39(4):1077-1097. PubMed ID: 31283452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of Multiple Myeloma.
    Kosmala A; Bley T; Petritsch B
    Rofo; 2019 Sep; 191(9):805-816. PubMed ID: 31185511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma.
    Gundesen MT; Asmussen JT; Haukås E; Schubert M; Abildgaard N; Schjesvold F; Lund T
    Eur J Haematol; 2022 May; 108(5):423-429. PubMed ID: 35113466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future imaging modalities for multiple myeloma and its precursor states.
    Tan E; Weiss BM; Mena E; Korde N; Choyke PL; Landgren O
    Leuk Lymphoma; 2011 Sep; 52(9):1630-40. PubMed ID: 21649546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Critical Role of Imaging in the Management of Multiple Myeloma.
    Raza S; Leng S; Lentzsch S
    Curr Hematol Malig Rep; 2017 Jun; 12(3):168-175. PubMed ID: 28317080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.